What does the Eucalyptus acquisition change for Hims & Hers in Australia?

Eucalyptus adds local clinics, clinicians, and brand trust, allowing Hims & Hers to expand faster across skincare, hair loss, sexual health, and weight care. It should cut time-to-market and improve refill rates. If integration stays smooth and compliant with Australian standards, the combined platform can lift cross-sell and retention across key categories.

How could the deal affect HIMS stock over the next quarter?

Near term, sentiment depends on guidance and regulatory clarity. An oversold setup, higher volume, and firm integration timelines could spark relief rallies. Conversely, delays, higher costs, or weak cross-sell signals may pressure shares. Watch the 23 February earnings call for details on synergies, customer acquisition costs, and margin trajectory.

Is Hims & Hers paying a fair price for Eucalyptus?

The tag is up to US$1.15 billion, about A$1.6 billion. Fairness hinges on retention of clinicians, customer growth, and cross-sell gains. If the deal shortens payback and lowers CAC in Australia, value creation improves. Earn-out structures can also align incentives if tied to measurable performance milestones.

What key metrics should Australian investors track post-close?

Focus on Australian cohort adds, repeat order rates, and category penetration. Monitor CAC, payback period, and marketing efficiency. Watch margin mix, leverage trends, and any updates on regulatory approvals. Clear progress on these items, matched with strong service levels, would support a stronger outlook for HIMS stock.

Global Market Insights

HIMS Stock Today: $1.15B Eucalyptus Deal Accelerates Global Push – February 20

ByDanny Kontos February 20, 2026February 20, 2026

HIMS stock is in focus on 20 February after Hims & Hers (HIMS) agreed to acquire Australia’s Eucalyptus in a deal valued at up to US$1.15 billion, or about A$1.6 billion. The Hims & Hers deal signals faster telehealth expansion across Australia and other new markets. For local investors, the Eucalyptus acquisition could boost brand reach in categories like skincare, hair loss, sexual health, and weight care. We break down what this means for growth, valuation, and risks that could sway HIMS stock near term.